Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors

被引:6
作者
Sobh, Eman A. [1 ,8 ]
Dahab, Mohammed A. [2 ,9 ]
Elkaeed, Eslam B. [3 ]
Alsfouk, Aisha A. [4 ]
Ibrahim, Ibrahim M. [5 ]
Metwaly, Ahmed M. [6 ,7 ]
Eissa, Ibrahim H. [2 ,9 ]
机构
[1] Menoufia Univ, Fac Pharm, Dept Pharmaceut Chem, Menoufia, Egypt
[2] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo, Egypt
[3] AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi Arabia
[4] Princess Nourah Bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi Arabia
[5] Cairo Univ, Fac Sci, Biophys Dept, Cairo, Egypt
[6] Al Azhar Univ, Fac Pharm Boys, Pharmacognosy & Med Plants Dept, Cairo, Egypt
[7] City Sci Res & Technol Applicat SRTA City, Genet Engn & Biotechnol Res Inst, Biopharmaceut Prod Res Dept, Alexandria, Egypt
[8] Menoufia Univ, Fac Pharm, Pharmaceut Chem Dept, Menoufia, Egypt
[9] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chemistry& Drug Design Dept, Cairo 11884, Egypt
关键词
Anti-proliferative; apoptosis; EGFR inhibitors; MD simulations; thieno[2; 3-d]pyrimidines; POTENTIAL VEGFR-2 INHIBITORS; TYROSINE KINASE INHIBITORS; RAPID COLORIMETRIC ASSAY; BIOLOGICAL EVALUATION; ANTICANCER EVALUATION; ACQUIRED-RESISTANCE; BINDING MODE; GROWTH; APOPTOSIS; DISCOVERY;
D O I
10.1080/14756366.2023.2220579
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A group of EGFR inhibitors derived from thieno[2,3-d]pyrimidine nucleus was designed, synthesised, and examined as anti-proliferative lead compounds. MCF-7 and A549 cell lines were inhibited by 5b, the most active member. It had inhibitory partialities of 37.19 and 204.10 nM against EGFR(WT) and EGFR(T790M), respectively. Compound 5b was 2.5 times safer against the WI-38 normal cell lines than erlotinib. Also, it demonstrated considerable potentialities for both early and late apoptosis induction in A549. Simultaneously, 5b arrested A549's growth at G1 and G2/M phases. Harmoniously, 5b upregulated the BAX and downregulated the Bcl-2 genes by 3-fold and increased the BAX/Bcl-2 ratio by 8.3-fold comparing the untreated A549 cells. Molecular docking against EGFR(WT) and EGFR(T790M) indicated the correct binding modes. Furthermore, MD simulations confirmed the precise binding of 5b against the EGFR protein over 100 ns. Finally, various computational ADMET studies were carried out and indicated high degrees of drug-likeness and safety.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation
    Lakkaniga, Naga Rajiv
    Gunaganti, Naresh
    Zhang, Lingtian
    Belachew, Binyam
    Frett, Brendan
    Leung, Yuet-Kin
    Li, Hong-yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 206
  • [22] Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell lines
    Salem, Mohamed S. H.
    Aziz, Yasmine M. Abdel
    Elgawish, Mohamed S.
    Said, Mohamed M.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2020, 94
  • [23] Design and Green Synthesis of Thieno[2,3-d]pyrimidine Analogues as Potential Antiproliferative Agents
    Gill, Rupinder Kaur
    Kumar, Virender
    Bishnoi, Mahendra
    Yadav, Kamalendra
    Kondepudi, Kanthi Kiran
    Bariwal, Jitender
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (05) : 701 - 711
  • [24] Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies
    Dhawale, Sachin A.
    Dabhade, Pratap S.
    Mokale, Santosh N.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (18) : 2042 - 2055
  • [25] New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies
    Sobh, Eman A.
    Dahab, Mohammed A.
    Elkaeed, Eslam B.
    Alsfouk, Bshra A.
    Ibrahim, Ibrahim M.
    Metwaly, Ahmed M.
    Eissa, Ibrahim H.
    MEDICINAL CHEMISTRY, 2024, 20 (09) : 876 - 899
  • [26] Design, synthesis and evaluation of anti-proliferative activity of 2-ary- l-4-aminoquinazoline derivatives as EGFR inhibitors
    Zhou, Zhihui
    He, Jie
    Yang, Feiyi
    Pan, Qingshan
    Yang, Zunhua
    Zheng, Pengwu
    Xu, Shan
    Zhu, Wufu
    BIOORGANIC CHEMISTRY, 2021, 112
  • [27] Synthesis of a new series of pyrimidine derivatives: exploration of anti-proliferative activity on EAT cells and molecular docking
    Senthilkumar, N.
    Ravichandran, Y. Dominic
    Kumar, K. M.
    Ramaiah, Sudha
    RESEARCH ON CHEMICAL INTERMEDIATES, 2016, 42 (02) : 1295 - 1313
  • [28] Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers
    Elzahabi, Heba S. A.
    Nossier, Eman S.
    Alasfoury, Rania A.
    El-Manawaty, May
    Sayed, Sara M.
    Elkaeed, Eslam B.
    Metwaly, Ahmed M.
    Hagras, Mohamed
    Eissa, Ibrahim H.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 1053 - 1076
  • [29] New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies
    Elkady, Hazem
    Abuelkhir, Abdelrahman A.
    Rashed, Mahmoud
    Taghour, Mohammed S.
    Dahab, Mohammed A.
    Mahdy, Hazem A.
    Elwan, Alaa
    Al-ghulikah, Hanan A.
    Elkaeed, Eslam B.
    Ibrahim, Ibrahim M.
    Husein, Dalal Z.
    Metwaly, Ahmed
    Eissa, Ibrahim H.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2023, 107
  • [30] Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
    Garcia, Santiago
    Mercado-Sanchez, Itzel
    Bahena, Luis
    Alcaraz, Yolanda
    Garcia-Revilla, Marco A.
    Robles, Juvencio
    Santos-Martinez, Nancy
    Ordaz-Rosado, David
    Garcia-Becerra, Rocio
    Vazquez, Miguel A.
    MOLECULES, 2020, 25 (21):